{
  "actions": [
    {
      "acted_at": "2001-05-16", 
      "references": [
        {
          "reference": "CR S5008-5009", 
          "type": null
        }
      ], 
      "text": "Sponsor introductory remarks on measure.", 
      "type": "action"
    }, 
    {
      "acted_at": "2001-05-16", 
      "committee": "Committee on Finance", 
      "references": [], 
      "status": "REFERRED", 
      "text": "Read twice and referred to the Committee on Finance.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "s895-107", 
  "bill_type": "s", 
  "committees": [
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "Senate Finance", 
      "committee_id": "SSFI"
    }
  ], 
  "congress": "107", 
  "cosponsors": [
    {
      "district": null, 
      "name": "Frist, William H.", 
      "sponsored_at": "2001-05-16", 
      "state": "TN", 
      "thomas_id": "01336", 
      "title": "Sen", 
      "withdrawn_at": null
    }, 
    {
      "district": null, 
      "name": "Lieberman, Joseph I.", 
      "sponsored_at": "2001-11-05", 
      "state": "CT", 
      "thomas_id": "01385", 
      "title": "Sen", 
      "withdrawn_at": null
    }, 
    {
      "district": null, 
      "name": "Murray, Patty", 
      "sponsored_at": "2001-11-05", 
      "state": "WA", 
      "thomas_id": "01409", 
      "title": "Sen", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2001-05-16", 
  "number": "895", 
  "official_title": "A bill to amend the Internal Revenue Code of 1986 to allow a credit against income tax for research related to developing vaccines against widespread diseases and ensure that such vaccines are affordable and widely distributed.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": "Vaccines for the New Millennium Act of 2001", 
  "sponsor": {
    "district": null, 
    "name": "Kerry, John F.", 
    "state": "MA", 
    "thomas_id": "01379", 
    "title": "Sen", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2001-05-16", 
  "subjects": [
    "AIDS (Disease)", 
    "Access to health care", 
    "Biotechnology", 
    "Business and social problems", 
    "Business income tax", 
    "Clinical trials", 
    "Commerce", 
    "Communicable diseases", 
    "Congress", 
    "Congressional reporting requirements", 
    "Developing countries", 
    "Drug industry", 
    "Economics and public finance", 
    "Government and business", 
    "Government operations and politics", 
    "Government trust funds", 
    "Governmental investigations", 
    "Health", 
    "Human immunodeficiency viruses", 
    "Income tax", 
    "Intellectual property", 
    "International affairs", 
    "International agencies", 
    "International cooperation", 
    "Malaria", 
    "Medical research", 
    "Microbiological research", 
    "Nongovernmental organizations", 
    "Nonprofit organizations", 
    "Patents", 
    "Pharmaceutical research", 
    "Prescription pricing", 
    "Price policy", 
    "Research and development tax credit", 
    "Science, technology, communications", 
    "Social welfare", 
    "Tax deductions", 
    "Taxation", 
    "Technology transfer", 
    "Trade secrets", 
    "Tuberculosis", 
    "Vaccines", 
    "World health"
  ], 
  "subjects_top_term": "Taxation", 
  "summary": {
    "as": "Introduced", 
    "date": "2001-05-16", 
    "text": "Vaccines for the New Millennium Act of 2001 - Amends the Internal Revenue Code to allow a limited business credit for the costs medical research related to developing vaccines against widespread diseases. Defines Widespread diseases as malaria, tuberculosis, HIV, or any infectious disease (of a single etiology) which, according to the World Health Organization, causes over one million human deaths annually.Allows a limited lifesaving vaccine sale credit equal to the amount of qualified vaccine sales. Defines qualified vaccine sales as the aggregate amount paid to the taxpayer for a qualified sale. Defines a qualified sale as a sale of a qualified vaccine: (1) to a nonprofit organization or to a government of any foreign country (or instrumentality of such a government); and (2) for distribution in a developing country.Establishes the Lifesaving Vaccine Purchase Fund.Expresses the sense of Congress concerning the manufacture, distribution, support for global efforts, and tiered pricing of vaccines."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "title": "Vaccines for the New Millennium Act of 2001", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "title": "A bill to amend the Internal Revenue Code of 1986 to allow a credit against income tax for research related to developing vaccines against widespread diseases and ensure that such vaccines are affordable and widely distributed.", 
      "type": "official"
    }
  ], 
  "updated_at": "2013-02-02T20:46:56-05:00"
}